HA
ARCT icon

Heartland Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Heartland Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
219,300
-36,700
-14% -$289K 0.07% 203
2026
Q1 		$1.98M Buy
+256,000
New +$1.87M 0.1% 199

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Heartland Advisors's ARCT Position: Q2 2026 in Review

Heartland Advisors reduced its Arcturus Therapeutics (ARCT) stake by 14% in Q2 2026, selling an estimated $289K and leaving 219,300 shares worth $1.47M. The position accounts for 0.07% of the portfolio, ranked #203.

Heartland Advisors first reported a position in ARCT in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.98M in Q1 2026. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • Heartland Advisors held 219,300 shares of Arcturus Therapeutics worth $1.47M as of Q2 2026.
  • Heartland Advisors sold 36,700 Arcturus Therapeutics shares in Q2 2026, an estimated $289K.
  • Arcturus Therapeutics made up 0.07% of Heartland Advisors's portfolio in Q2 2026, its #203 holding.
  • Heartland Advisors first reported a position in Arcturus Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Heartland Advisors's Arcturus Therapeutics position peaked at $1.98M in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on Heartland Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.